Form 4 for NVCR NovoCure Ltd
Accepted 2026-04-28 16:27:46 ET · period of report 2026-04-28 · accession 0001369091-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-28 16:27 | 2026-04-28 | NVCR | VERNON W ANTHONY | Dir | M - OptEx | $11.39 | +21.5K | 200.6K | +12% | +$244.9K |
| D | 2026-04-28 16:27 | 2026-04-28 | NVCR | VERNON W ANTHONY | Dir | M - OptEx | $0.00 | -21.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-04-28 | M | A | 21,500 | $11.39 | 200,602 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-04-28 | M | D | 21,500 | $0.00 | 0 | D | $11.39 · 2017-05-04 to 2026-05-04 | 21,500 Ordinary Shares |